MELISSA CYR: Open Payments
NPI 1053541003 · APEX, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 20 payments from 9 companies in 2025. Trend: 2023 $377 · 2024 $760 · 2025 $938
Food & beverage: $838Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $250 |
| GENZYME CORPORATION | 3 | $198 |
| UCB, Inc. | 3 | $151 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $134 |
| PFIZER INC. | 3 | $62 |
| ABBVIE INC. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Amgen Inc. | 1 | $29 |
| LNHC, Inc | 1 | $22 |
Products named: TREMFYA, DUPIXENT, Bimzelx, Winlevi, CIBINQO, SKYRIZI, OTEZLA, Rhapsido.
Industry payments across NC — which companies pay providers there.
